These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26795113)

  • 1. Design, synthesis and biological evaluation of novel analgesic agents targeting both cyclooxygenase and TRPV1.
    Yan L; Pan M; Fu M; Wang J; Huang W; Qian H
    Bioorg Med Chem; 2016 Feb; 24(4):849-57. PubMed ID: 26795113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of anti-inflammatory and analgesic effects of synthesized derivatives of ibuprofen.
    Wang J; Dai D; Qiu Q; Deng X; Lin H; Qian H; Huang W
    Chem Biol Drug Des; 2015 May; 85(5):623-32. PubMed ID: 24618048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Analogues of BCTC Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 Antagonists.
    Yan L; Wang J; Pan M; Qiu Q; Huang W; Qian H
    Chem Biol Drug Des; 2016 Feb; 87(2):306-11. PubMed ID: 26360809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
    García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
    J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel piperazine urea derivatives as highly potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Hu J; Gao M; Zhang Y; Wang Y; Qiao Z; Zhang W; Wang Q; Yan L; Qian H
    Bioorg Chem; 2021 Oct; 115():105229. PubMed ID: 34364049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of carbamide derivatives bearing tetrahydroisoquinoline moieties and biological evaluation as analgesia drugs in mice.
    Qiu Q; Wang J; Deng X; Qian H; Lin H; Huang W
    Arch Pharm (Weinheim); 2015 May; 348(5):347-52. PubMed ID: 25824579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel phenylpiperazine derivatives as potent transient receptor potential vanilloid 1 antagonists.
    Jing L; Liu C
    Chem Biol Drug Des; 2024 Jul; 104(1):e14584. PubMed ID: 38997239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of N
    Gao M; Nie C; Li J; Song B; Cheng X; Sun E; Yan L; Qian H
    Bioorg Chem; 2019 Feb; 82():100-108. PubMed ID: 30278281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature.
    Reilly RM; McDonald HA; Puttfarcken PS; Joshi SK; Lewis L; Pai M; Franklin PH; Segreti JA; Neelands TR; Han P; Chen J; Mantyh PW; Ghilardi JR; Turner TM; Voight EA; Daanen JF; Schmidt RG; Gomtsyan A; Kort ME; Faltynek CR; Kym PR
    J Pharmacol Exp Ther; 2012 Aug; 342(2):416-28. PubMed ID: 22570364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.
    Swanson DM; Dubin AE; Shah C; Nasser N; Chang L; Dax SL; Jetter M; Breitenbucher JG; Liu C; Mazur C; Lord B; Gonzales L; Hoey K; Rizzolio M; Bogenstaetter M; Codd EE; Lee DH; Zhang SP; Chaplan SR; Carruthers NI
    J Med Chem; 2005 Mar; 48(6):1857-72. PubMed ID: 15771431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamides, vanillylamides, ethanolamides, and arachidonic acid amides of anti-inflammatory and analgesic drug substances as TRPV1 ligands.
    Sinning C; Watzer B; De Petrocellis L; Di Marzo V; Imming P
    ChemMedChem; 2008 Dec; 3(12):1956-64. PubMed ID: 19003845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and preliminary biological evaluation of capsaicin derivatives as potential analgesic drugs.
    Qian H; Fu Z; Huang W; Zhang H; Zhou J; Ge L; Lin R; Lin H; Hu X
    Med Chem; 2010 Jul; 6(4):205-10. PubMed ID: 20843287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity.
    Nash MS; McIntyre P; Groarke A; Lilley E; Culshaw A; Hallett A; Panesar M; Fox A; Bevan S
    J Pharmacol Exp Ther; 2012 Aug; 342(2):389-98. PubMed ID: 22566669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
    Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
    J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Tamayo N; Liao H; Stec MM; Wang X; Chakrabarti P; Retz D; Doherty EM; Surapaneni S; Tamir R; Bannon AW; Gavva NR; Norman MH
    J Med Chem; 2008 May; 51(9):2744-57. PubMed ID: 18386885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
    Banerjee AG; Das N; Shengule SA; Srivastava RS; Shrivastava SK
    Eur J Med Chem; 2015 Aug; 101():81-95. PubMed ID: 26117820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazoles.
    Ognyanov VI; Balan C; Bannon AW; Bo Y; Dominguez C; Fotsch C; Gore VK; Klionsky L; Ma VV; Qian YX; Tamir R; Wang X; Xi N; Xu S; Zhu D; Gavva NR; Treanor JJ; Norman MH
    J Med Chem; 2006 Jun; 49(12):3719-42. PubMed ID: 16759115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; design, synthesis and biological evaluation as potential anti-inflammatory agents.
    Abdelazeem AH; Abdelatef SA; El-Saadi MT; Omar HA; Khan SI; McCurdy CR; El-Moghazy SM
    Eur J Pharm Sci; 2014 Oct; 62():197-211. PubMed ID: 24907682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Brown BS; Keddy R; Zheng GZ; Schmidt RG; Koenig JR; McDonald HA; Bianchi BR; Honore P; Jarvis MF; Surowy CS; Polakowski JS; Marsh KC; Faltynek CR; Lee CH
    Bioorg Med Chem; 2008 Sep; 16(18):8516-25. PubMed ID: 18722778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypeptide modulators of TRPV1 produce analgesia without hyperthermia.
    Andreev YA; Kozlov SA; Korolkova YV; Dyachenko IA; Bondarenko DA; Skobtsov DI; Murashev AN; Kotova PD; Rogachevskaja OA; Kabanova NV; Kolesnikov SS; Grishin EV
    Mar Drugs; 2013 Dec; 11(12):5100-15. PubMed ID: 24351908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.